Regeneron is a healthcare company that discovers, develops, manufactures, and markets a wide range of biologic drugs.
Scope
This 32-page PowerPoint based report gives an important expert analysis on how COVID-19 will affect Regeneron. Findings are based on the industry’s most comprehensive platform the Pharma Intelligence Center, including Deals, News, Drugs, Sales, Clinical Trials database and recent analysis.
Reasons to Buy
An overview of how Regeneron will be affected by the COVID-19 pandemic.